Pulsed vs. Continuous Red Light Therapy: Which Is Better?

Pulsed output delivers light in repeated on/off cycles instead of maintaining a steady beam. The relevant parameters are not frequency alone. Pulse width, duty cycle, peak irradiance, average irradiance, treatment time, wavelength, beam or array geometry, and total radiant exposure all affect the delivered protocol.

Research comparing pulsed wave (PW) and continuous wave (CW) photobiomodulation is scientifically interesting but does not support a universal claim that pulsing is better. Some laboratory and animal studies have reported differences between specific pulsed and continuous protocols, while human evidence remains limited and highly heterogeneous. A frequency that produced a result in one wavelength, dose, tissue model, or laser system cannot automatically be transferred to a different LED panel or treatment goal.

This guide explains what pulsing changes, what the current evidence can and cannot establish, how to interpret safety information, and which specifications buyers should request before comparing devices.

What is pulsed red light therapy and how does it differ from continuous wave?

Pulsed red light therapy continuous wave vs pulsed waveform diagram

Red and near-infrared photobiomodulation (PBM) uses non-ionizing optical radiation, commonly within approximately 600–1100 nm, to produce photochemical and photophysical responses in tissue. Mitochondrial cytochrome c oxidase is one proposed and widely studied photoacceptor, but PBM mechanisms are not limited to a single molecule. Research also discusses changes in reactive oxygen species signaling, nitric oxide, calcium signaling, membrane channels, transcription factors, and local circulation.

These mechanisms are wavelength-, dose-, tissue-, and context-dependent. They should not be described as proof that every red or near-infrared device will produce the same clinical outcome.

The basic delivery modes are:

• Continuous wave (CW): the source remains on at a nominally stable output throughout the exposure.
• Pulsed wave (PW): the source switches on and off according to a defined pulse structure.

One complete pulse cycle per second is 1 Hz. Twenty cycles per second is 20 Hz. Frequency, however, is only one part of the protocol.

The pulse parameters that must be reported together

1. Frequency (Hz): the number of pulse cycles per second.
2. Pulse width: the duration of each on-period, usually expressed in seconds, milliseconds, or microseconds.
3. Duty cycle: the percentage of each cycle during which the source is on.
4. Peak irradiance: the irradiance during the on-period, measured in mW/cm².
5. Average irradiance: the time-averaged irradiance over the complete pulse cycle.
6. Treatment time: the total exposure duration.
7. Radiant exposure: the delivered optical energy per unit area, measured in J/cm².

For an ideal rectangular pulse train:

Average irradiance = peak irradiance × duty cycle

Radiant exposure (J/cm²) = average irradiance (mW/cm²) × time (seconds) ÷ 1000

For example, 100 mW/cm² peak irradiance at a 50% duty cycle produces an average irradiance of approximately 50 mW/cm². A 10-minute session would therefore deliver approximately 30 J/cm² at the measurement plane, before accounting for treatment geometry and tissue losses.

This example also shows why frequency alone cannot define a dose. Two devices can both operate at 10 Hz while delivering very different optical exposures because their pulse width, duty cycle, peak irradiance, beam area, and session duration differ.

Intensity control is not automatically duty-cycle control

An important specification distinction is often missed:

• Frequency control changes how often the pulses repeat.
• Amplitude or intensity control changes the output level during emission.
• Duty-cycle control changes the proportion of time that the source is on.

A device with 0–100% intensity adjustment does not necessarily provide independent 0–100% duty-cycle control. Buyers should ask the manufacturer whether dimming is achieved through current control, pulse-width modulation, channel sequencing, or another method, and should request the actual pulse waveform measured at representative settings.

LED, laser, and broadband sources are not interchangeable

LED arrays can illuminate a relatively large area and can be switched at frequencies used in many PBM protocols. Their output is non-coherent and usually has a broader spectral bandwidth than a laser diode.

Laser systems produce a more directional beam and may deliver very different peak power, pulse width, spot size, and tissue irradiance. Results from a pulsed laser study should not be transferred directly to an LED panel merely because the two devices use the same nominal wavelength or frequency.

Broadband or filtered lamps may also deliver red or near-infrared light, but their spectrum, thermal output, beam geometry, and switching behavior differ from LED and laser systems.

The source type and complete optical protocol must therefore be considered when interpreting research.

Why did pulsing become a feature in photobiomodulation devices?

Photobiomodulation research timeline milestones 1960s to present

Modern PBM research is commonly traced to Endre Mester's low-power laser experiments in the 1960s. Those experiments helped establish interest in low-intensity light and tissue response, but they should not be presented as proof that pulsed emission is superior.

Pulsed delivery later became easier to implement as solid-state light sources, electronic drivers, and digital controls improved. At the same time, dose-response research showed that PBM outcomes may be biphasic: too little exposure may produce no measurable effect, while excessive irradiance, treatment time, or cumulative dose may reduce or reverse a desired response. That finding made temporal delivery pattern a valid research variable.

Adjustable Hz controls are now useful engineering features, especially where operators need repeatable settings. Their presence does not by itself prove that a device has a clinically validated protocol for sleep, mood, pain, skin care, or any other indication.

Is pulsing more effective than continuous red light therapy?

Continuous wave vs pulsed red light therapy study outcomes comparison

The most accurate conclusion is that pulsing may change biological responses under some experimental conditions, but no pulse frequency has been shown to be universally superior to continuous delivery.

A 2010 review of pulsed low-level light therapy found some evidence that pulsed and continuous light can have different effects, while also concluding that more work was needed to determine which pulse structures might be useful for specific conditions.

One frequently cited 2016 animal study compared continuous 810 nm laser exposure with 10 Hz and 100 Hz pulsed exposure at a 50% duty cycle in immunosuppressed rats. The 10 Hz protocol performed better on several wound-healing outcomes in that model. This is useful experimental evidence, but it is not a human trial and does not establish that 10 Hz is the optimal setting for other wounds, tissues, wavelengths, doses, LEDs, or consumer panels.

Why direct comparisons are difficult

Changing from continuous to pulsed output can also change:

• average irradiance;
• total radiant exposure;
• peak irradiance;
• thermal load;
• pulse width;
• source efficiency; and
• driver behavior.

If these variables are not controlled or clearly reported, an apparent pulse-frequency effect may actually reflect a dose difference. Strong CW-versus-PW studies should report the full optical protocol and explain whether groups were matched by peak irradiance, average irradiance, or total radiant exposure.

Does pulsing increase penetration depth?

Pulsing does not change the fundamental tissue absorption and scattering properties associated with wavelength. An 850 nm photon does not penetrate more deeply merely because the source is pulsed.

A pulsed system may produce a higher instantaneous irradiance during its on-period, but this does not automatically create a clinically meaningful penetration advantage. Tissue exposure still depends on wavelength, peak and average irradiance, spot or array geometry, distance, contact conditions, tissue type, and total dose.

Marketing claims that a certain frequency “pushes light deeper” should therefore be supported by model-specific optical measurements or tissue studies rather than by frequency alone.

Proposed mechanisms remain under investigation

Researchers have proposed that pulsing could:

• change the timing of mitochondrial and cellular signaling;
• alter nitric oxide or reactive oxygen species dynamics;
• reduce heat accumulation when average energy delivery is lower;
• permit higher instantaneous output within device or tissue constraints; or
• interact with excitable tissue in a frequency-dependent way.

These are research hypotheses and context-dependent observations, not universal explanations.

Visible-light flicker research at frequencies such as 40 Hz is also distinct from PBM dose research. Evidence that visible flicker can influence neural oscillations does not prove that a body panel pulsed at the same frequency will improve cognition, mood, or sleep. Such claims require direct trials using the same optical spectrum, intensity, treatment geometry, population, and outcome.

Potential applications: separate PBM evidence from pulse-specific evidence

Person using red light therapy panel for post workout muscle recovery in gym

Red and near-infrared PBM has been studied for a range of applications, including skin-related outcomes, wound healing, pain, exercise recovery, and neurological conditions. However, evidence for PBM in general should not be presented as evidence that pulsing is superior.

Skin and collagen-related applications

Much of the clinical and cosmetic literature on red-light skin applications uses continuous or incompletely reported output. Pulse-specific evidence is not yet strong enough to recommend one frequency for collagen production, skin rejuvenation, or facial treatment.

When comparing devices for skin applications, wavelength, average irradiance, treatment distance, session duration, uniformity, eye exposure, and total dose are more useful than a named Hz preset alone.

Wound and tissue repair

Laboratory and animal studies provide a rationale for continued research into pulsed PBM. The 810 nm rat study described above is one example of a frequency-dependent outcome under tightly defined conditions. Human evidence comparing otherwise matched pulsed and continuous protocols remains limited.

PBM should not replace established wound care, infection management, vascular assessment, or medical treatment. Open, chronic, infected, diabetic, or poorly healing wounds require professional evaluation.

Muscle recovery, joint comfort, and pain

Both continuous and pulsed PBM protocols appear in the musculoskeletal literature, but there is no universal irradiance threshold or pulse frequency that applies to every joint, muscle group, or condition.

The delivered dose depends on the actual irradiance at the body, exposure time, treated area, wavelength, tissue depth, device geometry, and treatment schedule. Statements such as “more than 100 mW/cm² is required” are too broad unless tied to a specific protocol and evidence source.

Neurological, sleep, and mood-related use

Transcranial PBM and visible-light entrainment are active research areas, but they are not interchangeable. A named preset should be treated as an operating mode, not as a medical efficacy claim. Users with neurological conditions should seek professional advice before applying pulsed visible light near the face or eyes.

Side effects, contraindications, and safe use

Pulsed red light therapy safe usage distance and eye protection infographic

Red and near-infrared PBM is generally described as non-ionizing and non-thermal when used within an appropriate protocol, but safety depends on wavelength, radiance or irradiance, exposure duration, viewing conditions, distance, pulse structure, device design, and the user.

Photosensitive seizure risk cannot be reduced to a single universal cutoff. An Epilepsy Foundation review identified bright flashes from approximately 3–60 Hz, particularly around 15–20 Hz, as a potential risk under specified visual conditions. Risk also depends on brightness, contrast, color, visual-field coverage, viewing distance, and individual susceptibility.

Eye protection should be based on the device assessment

Avoid direct viewing of high-output LED arrays. Use the supplied eye protection when the instructions require it, particularly for close facial exposure or visible pulsed modes.

At the same time, “goggles are always mandatory for every red-light product” is too broad as a technical statement. The appropriate control should be based on the model's optical output, IEC 62471 evaluation, intended distance, exposure duration, and instructions for use.

What IEC 62471 does—and does not—show

IEC 62471 provides exposure limits, measurement techniques, and a classification framework for photobiological hazards from electrically powered incoherent optical sources, including LEDs, across 200–3000 nm. The base standard excludes lasers.

An IEC 62471 test report can help buyers evaluate eye and skin exposure risk under the stated measurement conditions. It does not prove therapeutic efficacy, does not replace product-specific instructions, and should not be presented as a general medical approval.

Buyers should request a complete, model-specific report showing:

• tested model number;
• wavelength or spectral distribution;
• measurement distance;
• exposure duration or assessment basis;
• risk-group result;
• laboratory identity;
• report number and date; and
• any required labeling or user controls.

How to evaluate a pulsed red light therapy device

Pulsed red light therapy panel with labeled LED array and cooling specs

1. Verify wavelengths and spectral tolerance

Wavelength should be connected to the intended tissue and evidence base. Values such as 660 nm and 850 nm are common in red and near-infrared devices, but the nominal wavelength alone is insufficient.

Ask for:

• measured peak wavelengths and tolerance;
• spectral test method;
• channel configuration;
• whether wavelengths can operate separately or simultaneously; and
• output from each channel at the intended treatment setting.

2. Request irradiance at real treatment distances

Irradiance should be reported at the distance the user will actually maintain. A center-point maximum is not equivalent to the average exposure across the treatment area.

Useful test data include:

• distance from the emitting surface;
• warm-up period;
• instrument model and calibration status;
• center, minimum, maximum, and average irradiance;
• 3 × 3 or 5 × 5 measurement grid;
• uniformity calculation;
• spectral response of the meter; and
• output stability across the full session.

3. Separate peak irradiance from average irradiance

For pulsed modes, a buyer should be able to determine:

• peak irradiance during the on-period;
• pulse width;
• duty cycle;
• average irradiance;
• total treatment time; and
• calculated radiant exposure.

A headline value of 200 mW/cm² is incomplete if the specification does not state whether it is a peak or time-averaged measurement and at what distance it was obtained.

4. Confirm what the controls actually change

For any adjustable pulsed device, confirm:

• the frequency used by every named mode;
• whether intensity changes current amplitude or PWM duty cycle;
• whether red and near-infrared channels share the same pulse timing;
• whether the waveform remains stable at low and high settings; and
• whether the displayed setting matches measured optical output.

5. Examine thermal management and stability

Temperature changes can alter LED output and wavelength, so thermal management should support output stability during operation.

Buyers should still request warm-up and extended-run test results. A quoted LED life of 50,000 hours is meaningful only when drive current, junction temperature, thermal design, and the life-rating method are disclosed.

6. Check array uniformity

A high center-point reading can hide weak edges or hotspots. For full-body and professional panels, request an irradiance map at the stated treatment distance and calculate uniformity using the same method for every compared device.

7. Interpret compliance documents correctly

The FDA explicitly states that establishment registration or device listing does not denote approval, clearance, or authorization. Marketing should therefore use “FDA establishment registered” or accurately describe the relevant listing status—not “FDA certified” or “FDA approved” unless a specific FDA authorization supports that wording.

For the EU, a CE mark is not a general endorsement by an EU authority. Buyers should examine the applicable legislation, intended purpose, device classification, Declaration of Conformity, technical documentation, and notified-body information where required.

8. Evaluate OEM and production consistency

For OEM and private-label buyers, a protocol is useful only if production units reproduce the validated output.

Production validation should still include:

• model and bill-of-material control;
• optical output tolerances;
• waveform verification;
• thermal stability;
• electrical safety;
• aging tests;
• incoming-component control;
• traceability; and
• change-control procedures.

9. Use digital control for repeatability, not as proof of efficacy

Remote or app control can help clinics reproduce settings and document sessions. Useful records include wavelength channel, frequency, intensity, treatment time, operator, device serial number, and maintenance status.

Digital logging improves operational consistency. It does not validate a clinical claim unless the underlying protocol has appropriate evidence.

Key takeaways

• Pulsed red light therapy is defined by a complete pulse structure, not by Hz alone.
• Frequency, pulse width, duty cycle, peak irradiance, average irradiance, exposure time, and treatment geometry must be interpreted together.
• Pulsing may differ biologically from continuous output in specific experimental protocols, but there is no universally superior pulse frequency.
• Pulse frequency does not independently determine tissue penetration.
• A named preset mode is an equipment feature, not proof of clinical efficacy.
• Intensity control is not automatically independent duty-cycle control.
• Safety and compliance claims must be supported by model-specific reports and accurate regulatory language.

FAQ

What is pulsed red light therapy used for?

Pulsed PBM is investigated or used within protocols related to tissue repair, pain, musculoskeletal recovery, skin applications, and neurological research. However, many of these fields also use continuous output. Evidence for PBM generally should not be presented as proof that pulsing—or a particular frequency—is superior.

Should red light therapy be pulsed?

Not necessarily. Continuous output may be appropriate for many protocols and is often easier to dose. Pulsed output can provide additional control over temporal delivery, peak output, average irradiance, and heat, but only when the full waveform and dose are known. The correct choice depends on the application and supporting evidence.

Does 10 Hz, 20 Hz, or 40 Hz have a specific benefit?

No frequency has a universal effect independent of the rest of the protocol. A specific Hz value from a study applies to that study's wavelength, source, pulse width, duty cycle, irradiance, dose, tissue model, treatment schedule, and population. It should not be converted into a broad sleep, mood, joint, skin, or recovery claim without direct evidence.

Why is red light therapy not routinely recommended by every doctor?

Clinical adoption varies by indication. For some uses, evidence and professional guidelines are more developed; for others, studies are small, protocols differ, or long-term and comparative evidence is limited. Device intended use and regulatory status also vary. A consumer wellness product, an FDA-listed device, and a device with a specific FDA clearance are not equivalent categories.

What are the main risks of pulsed red light therapy?

Potential concerns include visual discomfort, excessive optical or thermal exposure, photosensitivity, and visually triggered seizures in susceptible individuals. Users should follow the model-specific instructions, avoid staring into the source, and seek medical advice when they have photosensitive epilepsy, use photosensitizing medication, or have a condition for which light exposure may be inappropriate.

Is pulsed red light therapy the same as IPL?

No. Photobiomodulation normally uses comparatively narrow red or near-infrared wavelength bands at non-ablative exposure levels. Intense Pulsed Light (IPL) uses high-intensity broadband pulses for dermatologic and cosmetic procedures such as hair reduction and treatment of pigmented or vascular lesions. The devices, energy levels, spectra, mechanisms, and risks are different.

References

1. Hashmi JT, et al. “Effect of Pulsing in Low-Level Light Therapy.” Lasers in Surgery and Medicine. 2010;42(6):450–466. PubMed
2. Keshri GK, et al. “Photobiomodulation with Pulsed and Continuous Wave Near-Infrared Laser (810 nm, Al-Ga-As) Augments Dermal Wound Healing in Immunosuppressed Rats.” PLOS ONE. 2016;11(11):e0166705. PubMed
3. Huang YY, et al. “Biphasic Dose Response in Low Level Light Therapy—An Update.” Dose-Response. 2011;9(4):602–618. PubMed
4. de Freitas LF, Hamblin MR. “Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.” IEEE Journal of Selected Topics in Quantum Electronics. 2016;22(3). PubMed
5. Fisher RS, et al. “Visually Sensitive Seizures: An Updated Review by the Epilepsy Foundation.” Epilepsia. 2022. PubMed
6. International Electrotechnical Commission. “IEC 62471:2006—Photobiological Safety of Lamps and Lamp Systems.” IEC
7. U.S. Food and Drug Administration. “Important Reminders about Registration and Listing.” FDA
8. European Commission. “CE Marking.” European Commission
9. International Organization for Standardization. “ISO 13485:2016—Medical Devices Quality Management Systems.” ISO

Related guides

Pulsed red light therapy sits at the intersection of optical engineering, device control, dosimetry, and biological research. These related resources expand on the parameters that matter most.

Related guides for pulsed red light therapy protocols and device selection

• How pulse frequency changes dose delivery—not optical penetration — explains frequency, pulse width, duty cycle, peak irradiance, and average irradiance without implying that Hz alone changes tissue optics.
• Continuous wave vs pulsed LED therapy: how to compare matched protocols — shows how to distinguish comparisons matched by peak irradiance, average irradiance, or total radiant exposure.
• Pulsed photobiomodulation evidence by application — separates human, animal, and laboratory evidence for skin, wound, musculoskeletal, and neurological research.
• Device buyer's guide: evaluating adjustable-pulse panels — covers irradiance at distance, array uniformity, waveform verification, thermal stability, and model-specific compliance documents.
• Should red light therapy be pulsed? A practical decision guide — maps when pulse control may add operational value and when continuous output is simpler to dose.

The most reliable protocol begins with complete parameters and realistic claims—not a frequency label by itself.